Chronicles of a small industrialist who dreams of re-enchanting France – Episode 65

Chronicles of a small industrialist dreaming of re-enchanting France – Episode 65:

Unity is strength.

Last Wednesday, we brought a collective together. It was important. Everyone around us who understood that only collective intelligence can make us shine again. For excellence. For patients.

Our researchers are world-class. So are our clinicians and practitioners. Our patients, and above all future generations, are watching us.
We cannot disappoint them.

So we are shaking up certainties. We are disrupting practices. We are changing the paradigm.

Thank you Frédéric Minssieux for showing us how to unite 3,500 people with a simple idea. It is incredible how you were able to transform CLAUGER through the adoption of AI with your 400 makers, in the spirit of the passion contagion of gamers. Bravo, it is inspiring; you are a role model for all industrialists!

Thank you Prof. Sébastien Viel, you are a pioneer and practitioner of cell and tissue therapies. Your assessment is brutal: without industrialization, without French excellence in Techbio, we will have to make choices to forgo certain treatments, to stop treating certain patients, certain rare diseases. The science is there. The solutions are possible. But we must scale up. We must produce. And if we want to be sovereign, the essential technological building blocks must be French. We are still masters of complex systems engineering. At Maison MGA, we have decided to get to work. For you, to give you the weapons necessary for your fight for patients.

Thank you Claire Lecroisey-Leroy, what energy! What you have done and the challenges you face command respect. The mRNA excellence platform fuels the most beautiful biotech factory in the world: Modulus in Neuville and Singapore. Maison MGA is so proud to have modestly contributed to this industrial cathedral! AI is everywhere in research and process engineering; the tools are perfectly aligned to accelerate development and then produce and deploy. The evidence is clear. To treat as many people as possible, we must industrialize. It is in Lyon and Boston that Sanofi has chosen to do so. Boston for scientific and academic power, for its talent, but in Lyon, we also have the “Watts.” And in Lyon, we also have the Clauger, the MGA and everyone who has inherited the legacy of the vallée de la Chimie, energy, and vaccines, and who makes complex systems engineering possible.

And of course, thank you, Pascale Bouillé! You embody our incredible project, The Drug Cell, so well! The more I watch you, the more I tell myself that no one else could better embody TDC! Our challenge is immense. But the patients are waiting for us.

Together, let us turn our dreams into memories!

Thank you Grégoire, Sylvain and Philippe!

Long live La French Fab!